News

Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (NASDAQ:BPTS), (Euronext Growth Paris:ALBPS), ("Biophytis" or…

2 years ago

FendX Reminds Shareholders of Webinar on April 11, 2024 to Showcase Recent Achievements and Provides Corporate Update

Oakville, Ontario--(Newsfile Corp. - April 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or…

2 years ago

ProAssurance Announces Dates for Release of First Quarter 2024 Results Release and Investor Teleconference

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended March 31, 2024 after the close of normal…

2 years ago

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services…

2 years ago

Board-Certified and Highly Accomplished Active Duty Military Ophthalmologist Now Treating Patients at LasikPlus Lexington

LEXINGTON, KY / ACCESSWIRE / April 8, 2024 / Kentucky-based ophthalmologist and LASIK eye surgeon Dr. Gregory Bryant Giles is…

2 years ago

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

Promising preclinical results obtained in obesity support the OBA Phase 2 clinical study expected to start mid-2024PARIS, FRANCE AND CAMBRIDGE,…

2 years ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023

WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on…

2 years ago

Board-Certified and Highly Accomplished, Active Duty Military Ophthalmologist Now Treating Patients at LasikPlus Louisville

LOUISVILLE, KY / ACCESSWIRE / April 8, 2024 / Kentucky-based ophthalmologist and LASIK eye surgeon Dr. Gregory Bryant Giles is…

2 years ago

Cantargia presents unique effects of nadunolimab in pancreatic cancer

LUND, SE / ACCESSWIRE / April 8, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented new…

2 years ago

Nava Health to Open Sixth Center in the Baltimore-Washington Metropolitan Area

New Hunt Valley, Maryland Center Expands the Company's Footprint to Meet Growing Demand for Integrative CareCOLUMBIA, MD / ACCESSWIRE /…

2 years ago